Independent Franchise Partners
US Equity Fund
Independent Franchise Partners CME Group Inc stake
total: 60
US Equity Fund CME trades
- Total transactions:
- 6
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 3
- Held since:
- 2020 Q4
- Held for:
- 5 quarters
- Latest activity:
- 2022 Q1
According to 2026 Q1 report, Independent Franchise Partners doesn't hold any CME Group Inc (CME) shares. To date, the estimated cost basis is nearly $182.11 for "buy" trades and estimated average "sell" price is $227.75. US Equity Fund first purchased CME in 2020 Q4, initially acquiring 205,578 shares. Since the initial investment in CME Group Inc (CME), US Equity Fund has made 5 more transactions.
When did Independent Franchise Partners sell CME Group Inc (CME)?
Independent Franchise Partners sold off the entire CME Group Inc (CME) position in 2022 Q1.
When did Independent Franchise Partners buy CME Group Inc (CME)?
Independent Franchise Partners first invested in CME Group Inc (CME) in 2020 Q4 at the reported quarter-end price of $182.05 per share.
What's the cost basis of US Equity Fund's CME stake?
The estimated cost basis for CME Group Inc (CME) stake is around $182.11 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $182.11
- Weighted AVG sell price:
- $227.75
Independent Franchise Partners's historical trades in CME Group Inc
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q1
|
0.00%
|
0
|
$228.46
|
|
-100% (-201,458)
|
-2.21%
|
|
2021 Q4
|
2.21%
|
201,458
|
$228.46
|
$46,025,095
|
-0.06% (-127)
|
-0%
|
|
2021 Q3
|
1.95%
|
201,585
|
$193.38
|
$38,982,507
|
-1.90% (-3,905)
|
-0.04%
|
|
2021 Q2
|
2.16%
|
205,490
|
$212.68
|
$43,703,613
|
-0.31% (-635)
|
-0.01%
|
|
2021 Q1
|
2.19%
|
206,125
|
$204.23
|
$42,096,909
|
+0.27% (+547)
|
+0.01%
|
|
2020 Q4
|
2.03%
|
$182.05
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.